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T
he looming pandemic of obesity and overweight,
driven by ready access to high-calorie food and
an increasingly sedentary way of life, poses a
severe threat to global public health. The patho-
logical accumulation of excess dysfunctional adipose tis-
sue that characterizes obesity is a major risk factor for
many other diseases, including type 2 diabetes, cardiovas-
cular disease, hypertension, stroke, arthritis, and various
types of cancer (1). A basic, but often misunderstood,
concept is that weight gain is caused by a fundamental
energy imbalance, when energy intake from food chroni-
cally exceeds energy expended by physical activity and
metabolic processes (Fig. 1). Humans have evolved efﬁ-
cient biological mechanisms to acquire and defend their
energy stores. A therapy for weight loss must, therefore,
involve a decrease in food intake and/or an increase in
energy expenditure.
In addition to the better-known white adipose tissue
that specializes in lipid storage and undergoes pathologi-
cal expansion during obesity, mammals are also equipped
with thermogenic brown adipose tissue (BAT). BAT
evolved in mammals to dissipate large amounts of chem-
ical energy as heat. Brown fat cells possess large numbers
of mitochondria that contain a unique protein called
uncoupling protein 1 (UCP1). UCP1 functions to dissipate
the proton motive force that is normally used to drive the
synthesis of cellular ATP (2). As a consequence of UCP1
action, the energy in the mitochondrial electrochemical
gradient is released in the form of heat. Indeed, BAT is a
key thermogenic tissue in rodents and other small mam-
mals, including newborn humans, that defends core body
temperature in cold weather. The sensation of cold causes
sympathetic nerves to release catecholamines in BAT that
stimulate proliferation and heat production by brown fat
cells (2). Studies in rodents have also unequivocally dem-
onstrated that BAT plays an essential role in energy
balance and that its activity profoundly inﬂuences body
weight (3). Though BAT persists as a distinct tissue in
small mammals, the major deposit of BAT in newborn
humans (between the shoulder blades) regresses shortly
after birth. Other depots of BAT have been known to exist
in adult humans for many decades; however, estimates of
its mass and activity had suggested that it would have a
negligible impact on whole-body energy homeostasis (4,5).
For these reasons, the role of BAT in adult human physi-
ology and metabolism has not been carefully examined
until now.
In this issue of Diabetes, the study by Saito et al. (6),
together with three recent reports in the New England
Journal of Medicine (7–9), unambiguously demonstrates
that healthy adult humans have signiﬁcant depots of
metabolically active BAT. Positron emission tomography
combined with computed tomography is commonly used
to detect highly metabolically active cancer cells based on
their uptake of large amounts of
18ﬂuoro-labeled 2-deoxy-
glucose (FDG). During such imaging studies, symmetri-
cally localized depots of fatty tissue were frequently
identiﬁed as hot spots for FDG uptake (rev. in 10). Though
these tissues had all the attributes of BAT, formal proof
has now been provided by Saito et al. and in the studies in
the New England Journal of Medicine. Speciﬁcally, tissue
biopsies corresponding to the positron emission tomog-
raphy–positive regions have the morphological and molec-
ular characteristics of BAT, including expression of the
BAT-speciﬁc protein UCP1. Perhaps most importantly, and
as expected of bona ﬁde BAT, the tissue identiﬁed in adult
humans is remarkably stimulated to take up glucose upon
exposure to cold. In fact, Saito et al. show that BAT
deposits are often or completely undetectable in people
who are kept warm.
The central question that must now be addressed is
whether BAT function signiﬁcantly impacts energy bal-
ance and human obesity. Classic experiments in rodents
have shown that BAT is activated and proliferates in
response to overfeeding (11). This so-called “diet-induced
adaptive thermogenesis” is an apparent compensatory
mechanism to limit excess weight gain and obesity. Over-
feeding studies in humans have provided evidence for
dramatic interindividual differences in the energy cost of
feeding (12–14). Both anecdotally and in controlled stud-
ies, it is known that individuals with similar dietary intake
and exercise regimes exhibit dramatic differences in their
tendency to gain weight. The extent to which BAT-medi-
ated adaptive thermogenesis could account for some of
this variability in metabolic efﬁciency is not known. The
consensus from the recent human BAT studies, and espe-
cially the large-scale analysis by Cypess et al. (7), suggests
an inverse correlation between BMI and BAT activity.
Saito et al. also provide compelling data that BAT activity
diminishes with age. This phenomenon would explain, at
least to some degree, the tendency for people to gain
weight during aging. Whether the age-related decline in
BAT activity is caused by reduced sympathetic nerve
function, reduced sensitivity of BAT to adrenergic signals,
or cell-autonomous decreases in brown adipocyte differ-
entiation or function is an open question for future exper-
iments. Altogether, these new data strongly suggest that
BAT, though often overlooked in human metabolism,
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Regardless of whether the BAT present in adult humans
affects total daily energy expenditure, increasing the
amount and/or function of this tissue could be a safe and
effective therapy to limit obesity. The last several years
have seen an explosion of information related to the
transcriptional control of brown fat cell development,
differentiation, and function. The Zn-ﬁnger transcriptional
regulator PR domain containing 16 (PRDM16) has recently
emerged as a dominant driver of brown fat cell fate
(15,16). Bone morphogenetic protein 7 (BMP7) was also
recently shown to speciﬁcally direct brown adipocyte
differentiation, including induction of Prdm16 and Ucp1
gene expression (17). Synthetic chemicals or endogenous
factors (e.g., BMP7 itself) that activate PRDM16 function
or mimic its action in brown adipocyte development may
be viable antiobesity drugs. Alternatively, it may be possi-
ble to engineer synthetic brown adipocytes ex vivo for
autologous transplantation. Of course, it will ﬁrst be
important to establish that these developmental pathways
are conserved in human BAT.
Although the idea of stimulating BAT activity to combat
obesity is a rational approach, it is also conceivable that
this would trigger counterregulatory mechanisms such as
increased appetite to maintain energy homeostasis and
preserve fuel reserves. Another potential concern is that
activation of an expanded BAT compartment to levels that
cause weight reduction may result in unacceptable heat
generation and even socially unacceptable perspiration.
The obesity ﬁeld has already learned that target-based side
effects can limit the utility of effective therapeutics; e.g.,
the anal leakage caused by inhibitors of lipid absorption
from the gastrointestinal tract has prevented widespread
use of these agents despite their efﬁcacy for weight loss.
Nevertheless, the new human data have invigorated inter-
est and excitement in the function and physiological
relevance of BAT. Hopefully, these ﬁndings can be trans-
lated into 1) a better understanding of the mechanisms
that work together to regulate body weight and 2) novel
therapeutic interventions to reduce the burden of obesity
in our society.
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